Fundraising FoxHAWKTAIL — 2024 Investments
8 investments dated 2024 · listed companies and verified rows first · show all
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO & Board Member)inSteven Paul, M.D.(Founder, Board Chair)inMichael Chen, Ph.D.(Co-Founder, Chief Scientific Officer)Michael Chen(Executive Officer)inLana Gladstein(Executive Officer)inAntony Loebel(Executive Officer)in
Co-investorsARCH Venture PartnersForesite CapitalGeneral AtlanticPureTech HealthSofinnova VenturesCPP Investments+4 more
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardNicholas Saccomano(Director)
Board seatAlda Leu Dennis· per SEC Form D
Co-investorsCantos VenturesGaingelsInitialized CapitalLifespan Vision VenturesMana VenturesSpacecadet Ventures+3 more
__Twitter.png)
BurnBot builds purpose-built, remotely controlled machines and services for wildfire mitigation, fuels management, vegetation control, and timber operations.
CleantechClimate TechHardwareRoboticsSouth San Francisco, US
Waleed Haddad(Founder)in
BoardAnukool Lakhina(Founder)in
Co-investorsAmerican Family VenturesConvective CapitalDBL PartnersDCVC (Data Collective)Ecosystem Integrity FundHike Ventures+9 more
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsAmino CollectiveBlueYard CapitalMK Venture CapitalOctopus VenturesAcequia Capital (AceCap)redalpine+1 more
Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.
BiotechHealthtechSan Diego, US
Rich Stoner(Founder)inDan Knudsen(Founder)Kevin Cooksy(Founder)in
Co-investorsKdT VenturesPhase Two Ventures
HoX develops hardware, software, and chemistry capabilities to integrate biological analysis into business and health applications.
AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSpokane, US
Phil Hofer(CTO & Cofounder)James van Alstine(CEO & Cofounder)
Co-investorsAtria Ventures
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Co-Founder)inMat Legut(Co-Founder and CEO)in
BoardVasudev Bailey(Director)in
Co-investorsArtis VenturesCivilization Ventures Management, LlcFusionGaingelsWingAlexandria+2 more
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)inLauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCarnrite VenturesCivilization Ventures Management, LlcGaingelsNZVC+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.